As GLP-1 medications become increasingly common in health care, the FDA's latest action is a reminder about the importance of eye health. This new development echoes AOA’s past recommendations for greater public awareness regarding potential ocular complications and advocating for a proactive approach to patient care.
— Curated from external eye-care sources for opthametry.com readers.
📰 Original Source: AOA News
Discover more from An Eye Care Blog
Subscribe to get the latest posts sent to your email.
